(RTTNews) - NAVER Corp. (NHNCF, 035420.KS), NVIDIA and Brookfield announced plans to expand Korea's sovereign AI factory infrastructure with investments that will grow the initial NVIDIA DSX AI factory deployment from 5…
(RTTNews) - Trip.com Group Limited (TCOM, 9961.HK) announced that it has received the administrative penalty decision issued by the State Administration for Market Regulation (SAMR) of the People's Republic of China.
(RTTNews) - Kuwait Petroleum Corporation or KPC announced that its wholly owned subsidiary, Kuwait Oil Company or KOC, has signed a US$16.0 billion lease-and-lease-back agreement covering its entire domestic and export …
Investors in Marvell Technology (NASDAQ: MRVL) have seen quite the volatility over the past few months. It is currently trending downward and it's is off about 34% from its all-time high, at the time of this writing. Ho…
(RTTNews) - Zevra Therapeutics, Inc. (ZVRA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the company's Marketing Autho…
Sam Altman is well known for leading OpenAI, the disruptive force that created the artificial intelligence (AI) revolution. But he is also a disruptive force as a backer of technologies across a range of industries, mos…
(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief.
A typical dividend raise from a blue chip stock usually isn’t very major, with most coming in the low single-digit range. That sure wasn’t the case with Bank of America (NYSE:BAC) on Friday, as the big lender cranked it…
(RTTNews) - SK Group and NVIDIA (NVDA) expanded their strategic collaboration with a $500-billion-plus initiative that spans AI factory development and next-generation memory. The two companies signed letters of intent …
(RTTNews) - Outlook Therapeutics (OTLK) announced that the FDA has approved LYTENAVA as the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of neovascular age-related macular degenera…
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
Corn futures were weak early on, but pulled more than 8 cents off the lows in the front months to close fractionally mixed. Some deferreds were down as much as 1 ¼. September was still up 19 ½ cents on the week, with De…
In this episode of Motley Fool Rule Breaker Investing, Motley Fool co-founder David Gardner and Motley Fool analyst Karl Thiel revisit the original investment theses for five stocks selected in the anxious days followin…
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium and Lou Whiteman, along with Motley Fool analyst Emily Flippen, discuss:
Explore the exciting world of Moderna (NASDAQ: MRNA) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential inv…
Live cattle futures are up 50 cents to a tick lower in the front months. Cash trade has picked up mostly to $230 across the country. The Friday Fed Cattle Exchange online auction showed no sales on the 1,530 head, with …
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
We use cookies to improve your experience and analyse site traffic. By continuing to browse, you agree to our use of cookies.